FONT-SIZE Plus   Neg

SFX Entertainment Prices IPO At $13/Share, At Top End Of Estimated Range

SFX Entertainment, Inc. (SFXE), the world's largest producer of live events and entertainment content focused exclusively on electronic music culture, announced the pricing of initial public offering of 20 million shares of common stock at $13 per share, which represents top end of expected range.

In the amended filing with the SEC, the company had expected to price the initial public offering of 4.65 million common shares of between $11.00 and $13.00 per share.

The New York based company shares are expected to begin trading on the NASDAQ Global Select Market under the ticker symbol "SFXE" on October 9, 2013.

SFX, which was founded in 2011, has granted the underwriters a 30-day option to purchase up to 3 million additional shares at the initial public offering price less the underwriting discount to cover over-allotments, if any.

UBS Securities LLC, Jefferies LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering, and Stifel, Nicolaus & Company, Incorporated and BTIG, LLC are acting as co-managers.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Follow RTT